Skip to main content
. 2024 Jun 27;62(6):myae040. doi: 10.1093/mmy/myae040

Table 5.

Drug susceptibility to other antifungal drugs

Author Number of isolates MIC method Micafungin Anidulafungin Caspofungin Amphotericin B Flucytosine
Al-obaid et al. 58 63 Vitek 2 YST AST/CLSI BPs R: 0, 0%
Range: 0.06–0.06
MIC50: 0.06
MIC90: 0.06
Not done R: 0, 0%
Range: 0.25–0.25
MIC50: 0.25
MIC90: 0.25
NWT: 0, 0%
Range: 0.25–0.5
MIC50: 0.25
MIC90: 0.5
R: 1, 1.6%
Range: 1.0–16
MIC50: 1
MIC90: 1
Arastehfar, Daneshnia, et al. 1 64 CLSI M27-A3 R: 2, 3.1%
GM: 0.05
Range: 0.008–1
MIC50: 0.06
MIC90: 0.25
R: 0, 0%
GM: 0.04
Range: 0.008–0.5
MIC50: 0.025
MIC90: 0.125
Not done NWT: 0, 0%
GM 0.64
Range: 0.125–2
MIC50: 0.5
MIC90: 1
Not done
Arastehfar et al. 21 161 CLSI M27-A3 R: 0, 0% R: 0, 0% Not done NWT: 0, 0% Not done
Castanheira et al. 26 227 CLSI M27-A3 R: 2, 0.9% R: 2, 0.9% R: 2, 0.9% NWT: 0, 0% Not done
Chapman et al. 16 24 Sensititre YeastOne/CLSI BPs R: 0, 0%
GM: 0.02
Range: <0.008–0.06
MIC90: 0.03
R: 0, 0%
GM: 0.03
Range: <0.015–0.12
MIC90: 0.06
R: 0, 0%
GM: 0.04
Range: 0.015–0.25
MIC90: 0.09
NWT: 0, 0%
GM: 0.65
Range: <0.12–1
MIC90: 1
NWT: 1, 4%
GM: 0.07
Range: <0.06–1
MIC90: 0.197
Chen et al. 31 344 Sensititre YeastOne/CLSI BPs R: 2, 0.6%
Range: 0.015–2
MIC50: 0.03
MIC90: 0.03
R: 2, 0.6%
Range: 0.008–1
MIC50: 0.06
MIC90: 0.12
R: 3, 0.9%
Range: 0.015–8
MIC50: 0.06
MIC90: 0.12
NWT: 0, 0%
Range: 0.25–1
MIC50: 1
MIC90: 1
NWT: 4, 1.2%
Range: 0.03–64
MIC50: 0.03
MIC90: 0.06
Fan et al. 32 585 Sensititre YeastOne/CLSI BPs R: 2, 0.4%
I: 0, 0%
GM: 0.03
MIC50: 0.03
MIC90: 0.03
R: 2, 0.4%
I: 2, 0.4%
GM: 0.07
MIC50: 0.06
MIC90: 0.25
R: 2, 0.4%
I: 0, 0%
GM: 0.04
MIC50: 0.03
MIC90: 0.06
NWT: 0, 0%
GM: 0.75
MIC50: 1
MIC90: 1
NWT: 3, 0.6%
GM: 0.07
MIC50: 0.03
MIC90: 0.12
Fernández-Ruiz et al. 11 56 EUCAST broth microdilution GM: 0.034
MIC90: 0.03
R: 2, 3.6%
GM: 0.034
MIC90: 0.03
GM: 0.41
MIC90: 0.5
R: 0, 0%
GM: 0.079
MIC90: 0.12
Not done
Guinea et al. 48 59 EUCAST and CLSI M27-A3 EUCAST
GM: 0.034
MIC90: 0.03
Range: ≤0.03–2
CLSI
R: 2, 3.4%
GM: 0.021
MIC90: 0.06
Range: 0.03–1
EUCAST
R: 2, 3.4%
GM: 0.034
Range: ≤0.03–1
MIC90: 0.03
CLSI
R: 2, 3.4%
GM: 0.014
Range: 0.017–2
MIC90: 0.03
EUCAST
GM: 0.41
Range:0.12–2
MIC90: 0.5
CLSI
R: 0, 0%
I: 1, 1.7%
GM: 0.12
Range: 0.015–0.5
MIC90: 0.25
EUCAST
GM: 0.079
Range: ≤0.03–0.5
MIC90: 0.12
CLSI
GM: 0.22
Range: 0.03–1
MIC90: 0.5
EUCAST
GM: 0.154
Range: ≤0.12–32
MIC90: 0.12
Guo et al. 39 160 CLSI M27-A3 R: 0, 0%
Range: 0.008–0.25
MIC50: 0.32
MIC90: 0.125
Not done R: 0, 0%
I: 9, 5.6%
Range: 0.008-0.5
MIC50: 0.125
MIC90: 0.25
NWT: 0, 0%
Range: 0.125–2
MIC50: 0.5
MIC90: 1
NWT: 0, 0%
Range: 0.064–0.125
MIC50: 0.064
MIC90: 0.064
Katsuragi et al. 35 11 CLSI M27-A3 Range: 0.06–2
MIC50: 0.06
MIC90: 0.13
Not done Not done Range: 0.13–1
MIC50: 0.25
MIC90: 0.5
NWT: 0, 0%
Range: 0.13–4
MIC50: 0.25
MIC90: 0.25
Liu et al. 10 248 Sensititre YeastOne/CLSI BPs R: 4, 1.6%
I: 2, 0.8%
Range: 0.015–2
MIC50: 0.03
MIC90: 0.03
R: 4, 1.6%
I: 1, 0.4%
Range: 0.03–2
MIC50: 0.12
MIC90: 0.25
R: 4, 1.6%
I: 2, 0.8%
Range: 0.015–>8
MIC50: 0.06
MIC90: 0.25
NWT: 0, 0%
Range: 0.12–2
MIC50: 0.5
MIC90: 1
NWT: 3, 1.2%
Range: <0.06–64
MIC50: 0.06
MIC90: 0.12
Medeiros et al. 27 12 CLSI M27-A3 R: 0, 0%
Range: <0.015–1.0
MIC50: <0.015
MIC90: 0.03
Not done Not done R: 0, 0%
Range: 0.06–1.0
MIC50: 0.25
MIC90: 1.0
Not done
Megri et al. 4 19 CLSI M27-A3 R: 0, 0% R: 0, 0% Not done NWT: 0, 0% Not done
Siopi et al. 28 23 Sensititre YeastOne/CLSI BPs R: 0, 0%
Range: 0.015–0.06
MIC50: 0.03
MIC90: 0.06
R: 0, 0%
Range: ≤0.015–0.12
MIC50: ≤0.015
MIC90: 0.06
R: 0, 0%
Range: 0.015–0.12
MIC50: 0.03
MIC90: 0.06
Not done NWT: 0, 0%
Range: ≤0.06–0.12
MIC50: ≤0.06
MIC90: 0.12
Tasneem et al. 29 26 CLSI M44-A disk diffusion Not done Not done Not done NWT: 0, 0% Not done
Xiao et al. 30 379 Sensititre YeastOne/CLSI BPs R: 0, 0%
GM: 0.03
Range: ≤0.008–0.06
R: 0, 0%
I: 11, 0.3%
GM: 0.05
Range: ≤0.015–0.5
R: 0, 0%
GM: 0.04
Range: 0.15–0.25
NWT: 0, 0%
GM: 0.68
Range: 0.25–1
NWT: 3, 1.1%
GM: 0.04
Range: ≤0.06→64

Note: Susceptibility values are expressed as minimum inhibitory concentrations (MICs) in mg/L. BPs, breakpoints, GM, Geometric mean, MIC50, minimum inhibitory concentration of 50% of isolates, MIC90, minimum inhibitory concentration of 90% of isolates; S, susceptible; SDD, susceptible dose dependent; I, intermediate; R, resistant; WT, wildtype; NWT, non-wild type. Data are given as provided in source documents.